Abstract
Dysproteinemia is an important disease entity characterized by excessive amounts of abnormal monoclonal proteins in the circulation. The patient may be asymptomatic or may have symptoms secondary to deposition in the organs. The symptoms depend on the organ involved and the severity of involvement. If the patient stays asymptomatic for a long period, disease may become widespread and the deposition of the abnormal protein may be extensive. It is not only important to diagnose the type of dysproteinemia, but is also important to find out the cause of dysproteinemia for appropriate treatment.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Korbet SM, Schwartz MM. Multiple myeloma. J Am Soc Nephrol. 2006;17(9):2533–45.
Herrera GA, Picken MM. Renal involvement in plasma cell dyscrasias. In: Jennette JC, Olson JL, Silva FG, D’Agati VD, editors. Hepinstall’s pathology of the kidney, 7th ed. Philadelphia: Wolters Kluwer, 2015. pp. 956–959.
Sanders PW, Booker BB. Pathobiology of cast nephropathy from human Bence Jones proteins. J Clin Invest. 1992;89:630.
Melato M, Falconieri G, Pascali E, Pezzoli A. Amyloid casts within renal tubules: a singular finding in myelomatosis. Virchows Arch A Pathol Anat Histol. 1980;387(2):133–45.
Herrera GA. Renal manifestations of plasma cell dyscrasias: an appraisal from the patients’ bedside to the research laboratory. Ann Diagn Pathol. 2000;4(3):174–200.
Kapur U, Barton K, Fresco R, Leehey DJ, Picken MM. Expanding the pathologic spectrum of immunoglobulin light chain proximal tubulopathy. Arch Pathol Lab Med. 2007;131(9):1368–72.
Larsen CP, Bell JM, Harris AA, et al. The morphologic spectrum and clinical significance of light chain proximal tubulopathy with and without crystal formation. Mod Pathol. 2011;24(11):1462–9.
Herrera GA. The contributions of electron microscopy to the understanding and diagnosis of plasma cell dyscrasia-related renal lesions. Med Electron Microsc. 2001;34(1):1–18.
Sharma SG, Bonsib SN, Gokden N. Light chain proximal tubulopathy: expanding the pathologic spectrum with deposition of crystalline-like inclusions in glomeruli and interstitium in addition to proximal tubules. ISRN Pathol. [541075]. 2012. doi:10.5402/2012/541075.
Nasr SH, Galgano SJ, Markowitz GS, et al. Immunofluorescence on pronase-digested paraffin sections: a valuable salvage technique for renal biopsies. Kidney Int. 2006;70(12):2148–51.
Lin J, Markowitz GS, Valeri AM, et al. Renal monoclonal immunoglobulin deposition disease: the disease spectrum. J Am Soc Nephrol. 2001;12(7):1482–92.
Ronco PM, Alyanakian MA, Mougenot B, et al. Light chain deposition disease: a model of glomerulosclerosis defined at the molecular level. J Am Soc Nephrol. 2001;12(7):1558–65.
Randall RE, Williamson WC Jr, Mullinax F, et al. Manifestations of systemic light chain deposition. Am J Med. 1976;60(2):293–9.
Said SM, Sanjeev S, Anthony VM, et al. Renal amyloidosis: origin and clinicopathologic correlations of 474 recent cases. CJASN. 2013;8(9):1515–23.
Larsen CP, Walker PD, Weiss DT, et al. Prevalence and morphology of leukocyte chemotactic factor 2-associated amyloid in renal biopsies. Kidney Int. 2010;77(9):816–9.
Said SM, Sethi S, Valeri AM, et al. Characterization and outcomes of renal leukocyte chemotactic factor 2-associated amyloidosis. Kidney Int. 2014;86(2):370–7.
Sethi S, Theis JD, Shiller SM, et al. Medullary amyloidosis associated with apolipoprotein A-IV deposition. Kidney Int. 2012;81(2):201–6.
Gillmore JD, Lachmann HJ, Rowczenio D, et al. Diagnosis, pathogenesis, treatment, and prognosis of hereditary fibrinogen Aα-Chain amyloidosis. J Am Soc Nephrol. 2009;20(2):444–51.
Sethi S, Theis JD, Quint P, et al. Renal amyloidosis associated with a novel sequence variant of gelsolin. Am J Kidney Dis. 2013;61(1):161–6.
Sanchorawala V. Light chain (AL) amyloidosis: diagnosis and treatment. Clin J Am Soc Nephrol. 2006;1(6):1331–41.
Leung N, Bridoux F, Hutchinson CA, et al. Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant. Blood. 2012;120(22):4292–5.
Bridoux F, Leung N, Hutchinson CA, et al. Diagnosis of monoclonal gammopathy of renal significance. Kidney Int. 2015;87(4):698–711.
Nasr SH, Satoskar A, Markowitz GS, et al. Proliferative glomerulonephritis with monoclonal IgG deposits. J Am Soc Nephrol. 2009;20(9):2055–64.
Larsen CP, Messias NC, Walker PD, et al. Membranoproliferative glomerulonephritis with masked monotypic immunoglobulin deposits. Kidney Int. In press.
Sethi S, Rajkumar SV. Monoclonal gammopathy-associated proliferative glomerulonephritis. Mayo Clin Proc. 2013;88(11):1284–93.
Gu X, Herrera GA. Light-chain-mediated acute tubular interstitial nephritis: a poorly recognized pattern of renal disease in patients with plasma cell dyscrasia. Arch Pathol Lab Med. 2006;130(2):165–9.
Dimopoulos MA, Galani E, Matsouka C. Waldenström’s macroglobulinemia. Hematol Oncol Clin North Am. 1999;13(6):1351–66.
Morel-Maroger L, Basch A, Danon F, et al. Pathology of the kidney in Waldenström’s macroglobulinemia. Study of sixteen cases. N Engl J Med. 1970;283(3):123–9.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Nicholas Cossey, L., Sharma, S.G. (2016). Renal Manifestations of Plasma Cell Neoplasms. In: Lorsbach, R., Yared, M. (eds) Plasma Cell Neoplasms. Springer, Cham. https://doi.org/10.1007/978-3-319-42370-8_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-42370-8_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-42368-5
Online ISBN: 978-3-319-42370-8
eBook Packages: MedicineMedicine (R0)